{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T19:34:01Z","timestamp":1790278441029,"version":"4.1.0"},"reference-count":15,"publisher":"American Academy of Pediatrics (AAP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,4,1]]},"abstract":"<jats:p>Pediatric thrombocytopenia has a wide differential diagnosis, and recently, genetic testing to identify its etiology has become more common. We present a case of a 16-year-old boy with a history of chronic moderate thrombocytopenia, who later developed constitutional symptoms and bilateral hand edema with cold exposure. Laboratory evaluation revealed evidence both of inflammation and elevated muscle enzymes. These abnormalities persisted over months. His thrombocytopenia was determined to be immune mediated. Imaging revealed lymphadenopathy and asplenia, and a muscle biopsy was consistent with tubular aggregate myopathy. Ophthalmology evaluation noted photosensitivity, pupillary miosis, and iris hypoplasia. Genetic testing demonstrated a pathogenic variant in STIM1 consistent with autosomal dominant Stormorken syndrome. Our case is novel because of the overlap of phenotypes ascribed to both gain-of-function and loss-of-function pathogenic variants in STIM1, thereby blurring the distinctions between these previously described syndromes. Pediatricians should consider checking muscle enzymes when patients present with thrombocytopenia and arthralgia, myalgia, and\/or muscle weakness. Our case highlights the importance of both multidisciplinary care and genetic testing in cases of chronic unexplained thrombocytopenia. By understanding the underlying genetic mechanism to a patient\u2019s thrombocytopenia, providers are better equipped to make more precise medical management recommendations.<\/jats:p>","DOI":"10.1542\/peds.2019-2081","type":"journal-article","created":{"date-parts":[[2020,3,31]],"date-time":"2020-03-31T12:25:19Z","timestamp":1585657519000},"source":"Crossref","is-referenced-by-count":6,"title":["Chronic Thrombocytopenia as the Initial Manifestation of <i>STIM1<\/i>-Related Disorders"],"prefix":"10.1542","volume":"145","author":[{"given":"Anjali","family":"Sura","sequence":"first","affiliation":[{"name":"Divisions of Pediatric Rheumatology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Jacher","sequence":"additional","affiliation":[{"name":"Pediatric Genetics,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"Neil","sequence":"additional","affiliation":[{"name":"Pediatric Neurology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"McFadden","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Michigan, Ann Arbor, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Walkovich","sequence":"additional","affiliation":[{"name":"Pediatric Hematology-Oncology and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Hannibal","sequence":"additional","affiliation":[{"name":"Pediatric Genetics,"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2020,4,1]]},"reference":[{"issue":"1","key":"2021121013123065800_B1","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1182\/asheducation-2017.1.385","article-title":"Hereditary thrombocytopenias: a growing list of disorders","volume":"2017","author":"Noris","year":"2017","journal-title":"Hematology (Am Soc Hematol Educ Program)"},{"issue":"5","key":"2021121013123065800_B2","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/hae.13255","article-title":"Bleeding is not the main clinical issue in many patients with inherited thrombocytopaenias","volume":"23","author":"Melazzini","year":"2017","journal-title":"Haemophilia"},{"issue":"3","key":"2021121013123065800_B3","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/jth.14377","article-title":"Diagnosis of hereditary platelet disorders in the era of next-generation sequencing: \u201cprimum non nocere\u201d","volume":"17","author":"Greinacher","year":"2019","journal-title":"J Thromb Haemost"},{"issue":"12","key":"2021121013123065800_B4","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1136\/jmedgenet-2014-102623","article-title":"Clinical, histological and genetic characterisation of patients with tubular aggregate myopathy caused by mutations in STIM1","volume":"51","author":"B\u00f6hm","year":"2014","journal-title":"J Med Genet"},{"key":"2021121013123065800_B5","doi-asserted-by":"crossref","first-page":"859","DOI":"10.3389\/fneur.2018.00859","article-title":"Stormorken syndrome caused by a p.R304W STIM1 mutation: the first Italian patient and a review of the literature","volume":"9","author":"Borsani","year":"2018","journal-title":"Front Neurol"},{"issue":"2","key":"2021121013123065800_B6","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1111\/ene.13545","article-title":"Corpus callosum agenesis, myopathy and pinpoint pupils: consider Stormorken syndrome","volume":"25","author":"Alonso-Jim\u00e9nez","year":"2018","journal-title":"Eur J Neurol"},{"issue":"9","key":"2021121013123065800_B7","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.nmd.2017.05.002","article-title":"Complex phenotypes associated with STIM1 mutations in both coiled coil and EF-hand domains","volume":"27","author":"Harris","year":"2017","journal-title":"Neuromuscul Disord"},{"issue":"3","key":"2021121013123065800_B8","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.ymgme.2014.12.307","article-title":"York platelet syndrome is a CRAC channelopathy due to gain-of-function mutations in STIM1","volume":"114","author":"Markello","year":"2015","journal-title":"Mol Genet Metab"},{"issue":"5","key":"2021121013123065800_B9","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1002\/humu.22544","article-title":"A dominant STIM1 mutation causes Stormorken syndrome","volume":"35","author":"Misceo","year":"2014","journal-title":"Hum Mutat"},{"issue":"10","key":"2021121013123065800_B10","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1002\/humu.22621","article-title":"Gain-of-function mutation in STIM1 (P.R304W) is associated with stormorken syndrome","volume":"35","author":"Morin","year":"2014","journal-title":"Hum Mutat"},{"issue":"11","key":"2021121013123065800_B11","doi-asserted-by":"crossref","first-page":"4197","DOI":"10.1073\/pnas.1312520111","article-title":"Activating mutations in STIM1 and ORAI1 cause overlapping syndromes of tubular myopathy and congenital miosis","volume":"111","author":"Nesin","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"2021121013123065800_B12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ceca.2018.07.008","article-title":"Gain-of-function mutations in STIM1 and ORAI1 causing tubular aggregate myopathy and Stormorken syndrome","volume":"76","author":"B\u00f6hm","year":"2018","journal-title":"Cell Calcium"},{"issue":"11","key":"2021121013123065800_B13","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1084\/jem.20101597","article-title":"Whole-exome sequencing-based discovery of STIM1 deficiency in a child with fatal classic Kaposi sarcoma","volume":"207","author":"Byun","year":"2010","journal-title":"J Exp Med"},{"issue":"19","key":"2021121013123065800_B14","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1056\/NEJMoa0900082","article-title":"STIM1 mutation associated with a syndrome of immunodeficiency and autoimmunity","volume":"360","author":"Picard","year":"2009","journal-title":"N Engl J Med"},{"issue":"3","key":"2021121013123065800_B15","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.jaci.2015.03.009","article-title":"A novel hypomorphic mutation in STIM1 results in a late-onset immunodeficiency","volume":"136","author":"Schaballie","year":"2015","journal-title":"J Allergy Clin Immunol"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2019-2081\/1078943\/peds_20192081.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2019-2081\/1078943\/peds_20192081.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,11]],"date-time":"2021-12-11T01:59:50Z","timestamp":1639187990000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/145\/4\/e20192081\/36945\/Chronic-Thrombocytopenia-as-the-Initial"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,1]]},"references-count":15,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2020,4,1]]},"published-print":{"date-parts":[[2020,4,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2019-2081","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,1]]},"article-number":"e20192081"}}